Research Article

Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial

Number: 26 August 31, 2025
EN TR

Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial

Abstract

Aim: Post-Covid syndrome (PCS) is a condition that becomes chronic after the acute phase of Covid-19 and affects systems such as respiratory, cardiovascular, nervous, and musculoskeletal, and negatively affects patients’ quality of life (QoL). The aim of this study was to investigate the effect of calisthenics exercises on QoL in patients with PCS. Method: A total of 176 patients (male: 82, female: 94) with PCS were included and randomized to therapist-supervised and home exercise groups in this study. The calisthenics exercise program was carried out for eight weeks in both groups. QoL was assessed by the European Quality of Life 5-Dimensional 3-Level (EQ-5D-3L) questionnaire at baseline and after eight weeks. Results: Significant improvements were obtained in all parameters of the EQ-5D-3L scale, including mobility, self-care, usual activities, pain/discomfort, anxiety/depression and general health score (p<0.05) in both therapist-supervised and home exercise groups. When therapist-supervised and home exercise groups were compared in terms of EQ-5D-3L, no significant difference was found between these groups (p>0.05). Conclusion: Calisthenics exercises cause a significant increase in the QoL in patients with Post-Covid syndrome when administered both as a therapist-supervised and home exercise program.

Keywords

References

  1. 1. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi: 10.1038/s41591-021-01283-z.
  2. 2. Goërtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542-2020. doi: 10.1183/23120541.00542-2020.
  3. 3. Khoreva MA. Postcovid syndrome - the new reality. Neurosci Behav Physiol. 2022;52(5):619-624. doi: 10.1007/s11055-022-01286-4.
  4. 4. Akbarialiabad H, Taghrir MH, Abdollahi A, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49(6):1163-1186. doi: 10.1007/s15010-021-01666-x.
  5. 5. Scholkmann F, May CA. COVID-19, post-acute COVID-19 syndrome (PACS, "long COVID") and post-COVID-19 vaccination syndrome (PCVS, "post-COVIDvac-syndrome"): Similarities and differences. Pathol Res Pract. 2023;246:154497. doi: 10.1016/j.prp.2023.154497.
  6. 6. Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93(2):1013-1022. doi: 10.1002/jmv.26368.
  7. 7. Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258-263. doi: 10.1016/j.cmi.2020.09.052.
  8. 8. Beyer S, Haufe S, Meike D, et al. Post-COVID-19 syndrome: Physical capacity, fatigue and quality of life. PLoS One. 2023;18(10):e0292928. doi: 10.1371/journal.pone.0292928.

Details

Primary Language

English

Subjects

Physiotherapy

Journal Section

Research Article

Early Pub Date

August 30, 2025

Publication Date

August 31, 2025

Submission Date

March 9, 2025

Acceptance Date

July 28, 2025

Published in Issue

Year 2025 Number: 26

APA
Perçin, A., Bilazer, S., Albayrak, H. E., Özdemir, C., & Koçak, C. (2025). Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial. Istanbul Gelisim University Journal of Health Sciences, 26, 451-463. https://doi.org/10.38079/igusabder.1654185
AMA
1.Perçin A, Bilazer S, Albayrak HE, Özdemir C, Koçak C. Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial. IGUSABDER. 2025;(26):451-463. doi:10.38079/igusabder.1654185
Chicago
Perçin, Alper, Sena Bilazer, Havva Ezgi Albayrak, Cansu Özdemir, and Cahidenur Koçak. 2025. “Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial”. Istanbul Gelisim University Journal of Health Sciences, nos. 26: 451-63. https://doi.org/10.38079/igusabder.1654185.
EndNote
Perçin A, Bilazer S, Albayrak HE, Özdemir C, Koçak C (August 1, 2025) Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial. Istanbul Gelisim University Journal of Health Sciences 26 451–463.
IEEE
[1]A. Perçin, S. Bilazer, H. E. Albayrak, C. Özdemir, and C. Koçak, “Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial”, IGUSABDER, no. 26, pp. 451–463, Aug. 2025, doi: 10.38079/igusabder.1654185.
ISNAD
Perçin, Alper - Bilazer, Sena - Albayrak, Havva Ezgi - Özdemir, Cansu - Koçak, Cahidenur. “Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial”. Istanbul Gelisim University Journal of Health Sciences. 26 (August 1, 2025): 451-463. https://doi.org/10.38079/igusabder.1654185.
JAMA
1.Perçin A, Bilazer S, Albayrak HE, Özdemir C, Koçak C. Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial. IGUSABDER. 2025;:451–463.
MLA
Perçin, Alper, et al. “Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial”. Istanbul Gelisim University Journal of Health Sciences, no. 26, Aug. 2025, pp. 451-63, doi:10.38079/igusabder.1654185.
Vancouver
1.Alper Perçin, Sena Bilazer, Havva Ezgi Albayrak, Cansu Özdemir, Cahidenur Koçak. Comparison of Therapist-Supervised and Home Exercise Calisthenics Exercises in Post-Covid Syndrome: A Single Blind, Randomized Controlled Trial. IGUSABDER. 2025 Aug. 1;(26):451-63. doi:10.38079/igusabder.1654185

 Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)